We are live on ! Find out more
PHXM

PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM

Delisted

PHXM was delisted on the 8th of March, 2024.

Back to rankings

5 hedge funds and large institutions have $11.1M invested in PHAXIAM Therapeutics S.A.. American Depositary Shares in 2019 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

12% more capital invested

Capital invested by funds: $9.9M → $11.1M (+$1.2M)

0% more funds holding

Funds holding: 5 → 5 (0)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$8.34K
Name Holding Trade Value Shares
Change 		Change in
Stake
BI
1
BVF Inc
California
$4.75M – – –
NMC
2
NEA Management Company
Maryland
$4.74M – – –
SFM
3
Sphera Funds Management
Israel
$912K – – –
DG
4
Delek Group
Israel
$528K – – –
Millennium Management
5
Millennium Management
New York
$172K -$8.34K -100 -4%

PHXM Hedge Fund Activity: Q1 2019 in Review

5 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) for Q1 2019, worth a combined $11.1M — up 12% from $9.9M a quarter earlier.

Fund positioning in PHXM was balanced in Q1 2019: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.

The largest seller was Millennium Management, cutting an estimated $8.34K.

  • 5 institutional investors held PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) as of Q1 2019, unchanged from Q4 2018.
  • Funds reported $11.1M of PHAXIAM Therapeutics S.A.. American Depositary Shares stock for Q1 2019, up 12% quarter-over-quarter.
  • 0 funds opened new PHAXIAM Therapeutics S.A.. American Depositary Shares positions in Q1 2019 and 0 closed out.
  • The largest PHAXIAM Therapeutics S.A.. American Depositary Shares seller in Q1 2019 was Millennium Management, an estimated $8.34K sold.

Based on aggregated 13F filings for Q1 2019.